CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience

被引:0
|
作者
Yong Wang
Hong-wei Zhao
Xiao-jiao Zhang
Bao-jun Chen
Guo-ning Yu
Ai-jie Hou
Bo Luan
机构
[1] The Peple’s Hospital of China Medical University,Department of Cardiology
[2] The Peple’s Hospital of Liaoning Province,Department of Science and Education
[3] The Peple’s Hospital of China Medical University,undefined
[4] The Peple’s Hospital of Liaoning Province,undefined
来源
BMC Cardiovascular Disorders | / 19卷
关键词
Chronic total occlusion; CHA2DS2-VASC score; Percutaneous coronary intervention; Contrast-induced nephropathy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Novel risk scoring for pre-procedural prediction of contrast-induced nephropathy and poor long-term outcomes among patients with chronic total occlusion undergoing percutaneous coronary intervention
    Liu, Yong
    Liu, Yuan-Hui
    Tan, Ning
    Chen, Ji-Yan
    Zhou, Ying-Ling
    Duan, Chong-Yang
    Li, Hua-Long
    Chen, Ping-Yan
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2015, 17 (0C) : C34 - C41
  • [33] Percutaneous coronary intervention for chronic total occlusion in 1263 patients: a single-center report
    Han Ya-ling
    Wang Shou-li
    Jing Quan-min
    Li Yi
    Zhang Jian
    Ma Ying-yan
    Luan Bo
    CHINESE MEDICAL JOURNAL, 2006, 119 (14) : 1165 - 1170
  • [34] Prognostic value of CHADS2and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Ma, Xiaoteng
    Shao, Qiaoyu
    Dong, Lisha
    Cheng, Yujing
    Lv, Sai
    Shen, Hua
    Liang, Jing
    Wang, Zhijian
    Zhou, Yujie
    MEDICINE, 2020, 99 (30) : E21321
  • [35] CHA2DS2-VASc score as a predictor of no-reflow phenomenon after saphenous vein graft percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes
    Gurbak, Ismail
    Panc, Cafer
    Sahin, Ahmet A.
    Dervis, Emir
    Yildiz, Ibrahim
    Guler, Arda
    Demir, Ali R.
    Kahraman, Serkan
    Uzun, Fatih
    KARDIOLOGIA POLSKA, 2020, 78 (11) : 1129 - 1136
  • [36] CHADS2 and CHA2DS2-VASc Scores in the Prediction of Thromboembolism Events in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Stenting
    He, Zhe
    Gao, HaiYang
    Yang, YueJin
    Xu, Bo
    Qiao, ShuBin
    Yao, Min
    Liu, HaiBo
    You, ShiJie
    Chen, Jue
    Qin, XueWen
    Wu, YongJian
    CIRCULATION, 2013, 128 (22)
  • [37] CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions
    Chou, Ruey-Hsing
    Huang, Po-Hsun
    Hsu, Chien-Yi
    Leu, Hsin-Bang
    Huang, Shao-Sung
    Huang, Chin-Chou
    Chen, Jaw-Wen
    Lin, Shing-Jong
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2016, 115 (07) : 501 - 509
  • [38] Contemporary Use and Effectiveness of N-Acetylcysteine in Preventing Contrast-Induced Nephropathy Among Patients Undergoing Percutaneous Coronary Intervention
    Gurm, Hitinder S.
    Smith, Dean E.
    Berwanger, Otavio
    Share, David
    Schreiber, Theodore
    Moscucci, Mauro
    Nallamothu, Brahmajee K.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (01) : 98 - 104
  • [39] Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents
    Kurtul, Alparslan
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (04) : 589 - 595
  • [40] CHA2DS2-VASc score predicts the slow flow/no-reflow phenomenon in ST-segment elevation myocardial infarction patients with multivessel disease undergoing primary percutaneous coronary intervention
    Huang, Xin
    Zheng, Wen
    Zhao, Xue Dong
    Nie, Shao Ping
    MEDICINE, 2021, 100 (21) : E26162